LORVOTUZUMAB MERTANSINE IN TREATING YOUNGER PATIENTS WITH RELAPSED OR REFRACTORY WILMS TUMOR, RHABDOMYOSARCOMA, NEUROBLASTOMA, PLEUROPULMONARY BLASTOMA, MALIGNANT PERIPHERAL NERVE SHEATH TUMOR, OR SYNOVIAL SARCOMA: